NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment
source: pixabay.com

NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment

According to a story from globenewswire.com, the biopharmaceutical company Apellis Pharmaceuticals, Inc. has announced that it is currently making plans to submit a New Drug Application (NDA) to the US…

Continue Reading NDA to be Submitted for Potential Paroxysmal Nocturnal Hemoglobinuria Treatment
Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation
source: pixabay.com

Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation

Immune-Onc Therapeutics recently received clearance from the FDA to begin trials of IO-202, a treatment for acute myeloid leukemia (AML). This news comes after the cancer immunotherapy company filed an…

Continue Reading Acute Myeloid Leukemia Treatment Granted the Investigational New Drug Designation

Sixty Year Old Multiple Myeloma Patient in Wuhan, China Treated Successfully with Tocilizumab for COVID-19

  Dr. Changcheng Zheng of the University of Science, China, recently spoke to Cancer Network about a case study indicating that tocilizumab (Actemra) could effectively treat people with multiple myeloma…

Continue Reading Sixty Year Old Multiple Myeloma Patient in Wuhan, China Treated Successfully with Tocilizumab for COVID-19
Scientists Explore the Epigenetic Causes of PAH
Photo by Robina Weermeijer on Unsplash

Scientists Explore the Epigenetic Causes of PAH

  Recently, researchers from European Molecular Biology Laboratory (EMBL) looked to understand the cause of pulmonary arterial hypertension (PAH). They collaborated with Stanford University through the Life Sciences Alliance. Because…

Continue Reading Scientists Explore the Epigenetic Causes of PAH
Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder
source: pixabay.com

Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder

  In an article in Medical Xpress, Japanese doctors have performed a “first” by transplanting liver cells (made with embryonic stem cells) into a newborn. The six-day-old infant was diagnosed with…

Continue Reading Doctors in Japan Transplant Stem Cells in Six-Day Old Newborn to Treat Urea Cycle Disorder
Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA
source: pixabay.com

Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

According to a story from prnewswire.com, the Chiesi Global Rare Diseases and the biopharmaceutical company ProTalix Biotherapeutics have recently announced that they have submitted a Biologics License Application (BLA) for…

Continue Reading Fabry Disease: A Biologics License Application for Pegunigalsidase Alfa has Been Submitted to the FDA

An App in New Zealand Allows IBD Patients to Communicate with Their Specialists Virtually

IBDsmart Researchers at the University of Otago, led by Michael Shultz, have developed a new app called IBDsmart to help patients with ulcerative colitis or Crohn's disease receive care remotely.…

Continue Reading An App in New Zealand Allows IBD Patients to Communicate with Their Specialists Virtually
Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease
source: pixabay.com

Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease

According to a story from Pulmonology Advisor, a recent study has evaluated risk factors for the appearance of bronchiectasis in patients with aspirin-exacerbated respiratory disease (AERD). A small number of…

Continue Reading Study Identifies Bronchiectasis Risk Factors in Aspirin-Exacerbated Respiratory Disease